Abstracts tagged "foot care"

Abstract Number: 412 • 2017 ACR/ARHP Annual Meeting
Baseline Values for Plantar Pressure and Background Characteristics As Indicators for the Limit of Conservative Treatment of Rheumatoid Forefoot Deformity
Hyunho Lee¹, Hajime Ishikawa¹, Asami Abe¹, Yumi Nomura¹, Eriko Hasegawa¹, Chinatsu Takai¹, Daisuke Kobayashi¹, Hiroshi Otani¹, Satoshi Ito¹, Takanobu Sumino², Takao Ishii², Shu Saito³, Yasuaki Tokuhashi⁴, Kiyoshi Nakazono¹ and Akira Murasawa¹, ¹Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan, ²Department of Orthopaedic Surgery, Kawaguchi Municipal Medical Center, Kawaguchi, Japan, ³Department of Orthopaedic Surgery, Nihon University School of Medicine, Itabishi, Japan, ⁴Department of Orthopaedic Surgery, Nihon University School of Medicine, Itabiashi, Japan
Background/Purpose: Forefoot deformities are commonly seen in patients with RA. It has been reported that nearly 90% of the patients have foot problems.1,2 Patients with…
Abstract Number: 2090 • 2013 ACR/ARHP Annual Meeting
The Effects of Commercially Available Footwear On Foot Pain and Disability in People With Gout: A Feasibility Study
Keith Rome¹, Sarah Stewart², Alain Vandal^3,4, Peter J. Gow⁵, Peter J. McNair² and Nicola Dalbeth⁶, ¹Health & Rehabilitation Research Institute, Auckland, New Zealand, AUT University, Auckland, New Zealand, ²Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand, ³Faculty of Health and Environmental Sciences, AUT University, Auckland, New Zealand, ⁴Counties Manukau District Health Board, Auckland, New Zealand, ⁵Rheumatology Dept, Middlemore Hospital, Auckland, New Zealand, ⁶Medicine, University of Auckland, Auckland, New Zealand
Background/Purpose: The non-pharmacological management goals for people with foot-related rheumatic diseases are pain management, preservation of foot function and patient mobility. One of the therapeutic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].